[Skip to Content]
[Skip to Content Landing]
Views 294
Citations 0
Comment & Response
April 2018

Evidence-Based Rationale for Use of Inferior Vena Cava Filters

Author Affiliations
  • 1Vascular and Interventional Radiology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire
  • 2Radiology, Geisel School of Medicine, Lebanon, New Hampshire
JAMA Intern Med. 2018;178(4):573-574. doi:10.1001/jamainternmed.2018.0058

To the Editor Inferior vena cava (IVC) filters are used to prevent deep vein thromboses from becoming pulmonary emboli (PE). In an Editor’s Note in a recent issue of JAMA Internal Medicine, Dr Redberg argues that the absence of evidence of benefit and the definite harms of IVC filters warrants a moratorium on their use.1 This is a step away from evidence-based medicine. Admittedly, there is limited evidence of benefit, but what evidence exists is scientifically sound; the PREPIC prospective randomized study2 8-year data clearly showed a 50% decrease in PE risk after IVC filter placement. On the other hand, there are no large IVC filter studies that support the claim of an increase in clinically significant negative outcomes.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Limit 140 characters
Limit 3600 characters or approximately 600 words